Agile therapeutics (agrx) came out with a quarterly loss of $0.20 per share versus the zacks consensus estimate of a loss of $0.23. Wall street stock market & finance report, prediction for the future:
Agile therapeutics (agrx) came out with a quarterly loss of $0.18 per share versus the zacks consensus estimate of a loss of $0.19.
Agrx stock forecast zacks. Agile therapeutics inc () stock market info recommendations: A quarter ago, it was expected that this. You'll find the agile therapeutics share forecasts, stock quote and buy / sell signals below.according to present data agile therapeutics's agrx shares and potentially its market environment have been in bearish.
This compares to loss of $0.10 per share a. The average price target represents a 513.88% upside from the last price of $0.55. 13, 2021 when the stock price was at 0.79$.
Agrx | complete agile therapeutics inc. Is currently rated as a zacks rank 3 and we are expecting an inline return from the agrx shares. This compares to loss of $0.10 per share a.
This suggests a possible upside of 431.0% from the stock's current price. This compares to loss of $0.18. This compares to loss of $0.12 per share a year ago.
By zacks equity research published on july 26,2021. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Agrx stock forecast our latest prediction for agile therapeutics inc's stock price was made on the oct.
On average, they expect agile therapeutics' share price to reach $3.38 in the next year. Investors will be thrilled if agrx’s share price rises to $4.00, which is the median consensus price. Want the latest recommendations from zacks investment research?
Buy or sell agile therapeutics stock? Volume fell on the last day along with the stock, which is. 2 wall street analysts that have issued a 1 year agrx price target, the average agrx price target is $3.75, with the highest agrx stock price forecast at $5.00 and the lowest agrx stock price forecast at $2.50.
(agrx) stock quote, history, news and other vital information to help you with your stock trading and investing. This quarterly report represents an earnings surprise of 4.76%. The average price target is $3.38, with a high forecast of $6.00 and a low forecast of $1.03.
This chart shows the closing price for agrx for the last year in relation to. Agile therapeutics (agrx) reports q2 loss, lags revenue estimates. Agile therapeutics (agrx) came out with a quarterly loss of $0.18 per share versus the zacks consensus estimate of a loss of $0.19.
Their forecasts range from $1.03 to $6.00. This compares to loss of $0.18 per share a. Find the latest agile therapeutics, inc.
Click to get this free report agile therapeutics, inc. Today, you can download 7 best stocks for the next 30 days. Agile therapeutics (agrx) came out with a quarterly loss of $0.20 per share versus the zacks consensus estimate of a loss of $0.21.
In the medium term (3months), agrx's stock price. Do the numbers hold clues to what lies ahead for the stock? Agile therapeutics (agrx) came out with a quarterly loss of $0.20 per share versus the zacks consensus estimate of a loss of $0.22.
Zacks' proprietary data indicates that agile therapeutics, inc.
